About Echelon Biosciences
Echelon Biosciences is a company based in Salt Lake City (United States) founded in 1997 was acquired by VION Biosciences in August 2024. Echelon Biosciences offers products and services including Lipids, Bioassays & Kits, Antibodies & Proteins, Peptides, and Biochemical Reagents. Echelon Biosciences operates in a competitive market with competitors including GlyTech, Iceni Glycoscience, GlycoSpot, Avanti Polar Lipids and TFChem, among others.
- Headquarter Salt Lake City, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$399.29 K (USD), Grant
Sep 20, 2024
-
Investors
NIH
& 4 more
-
Employee Count
Not available
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Echelon Biosciences
Echelon Biosciences offers a comprehensive portfolio of products and services, including Lipids, Bioassays & Kits, Antibodies & Proteins, Peptides, and Biochemical Reagents.
Products for lipid research and disease diagnostics
Kits for running samples in assays
Antibodies for protein detection in research
Peptides for scientific synthesis and analysis
Reagents for lipid and cell signaling studies
People of Echelon Biosciences
Unlock access to complete
Funding Insights of Echelon Biosciences
Investors in Echelon Biosciences
Echelon Biosciences has secured backing from 5 investors, including institutional investors. Prominent investors backing the company include NIH, HHS and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drug discovery services are provided to the biopharma sector.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Locked | Locked | Locked |
Investor details for Echelon Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Echelon Biosciences
Investment portfolio details for Echelon Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Echelon Biosciences
Detailed financials for Echelon Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Echelon Biosciences Comparisons
Peer comparison for Echelon Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Echelon Biosciences
Echelon Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GlyTech, Iceni Glycoscience, GlycoSpot, Avanti Polar Lipids and TFChem, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Human-type Asp-linked glycans are supplied for research applications.
|
|
| Locked | Locked | Locked |
Glycoscience platform is provided for diagnostic and therapeutic applications.
|
|
| Locked | Locked | Locked |
High-throughput enzyme screening solutions are developed and provided.
|
|
| Locked | Locked | Locked |
Phospholipids and lipids are manufactured for life science applications.
|
|
| Locked | Locked | Locked |
Fluoride chemistry is utilized to design glycomimetic drug compounds.
|
Detailed competitors of Echelon Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Echelon Biosciences
Complete news archive for Echelon Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Echelon Biosciences
Echelon Biosciences was founded in 1997 and raised its 1st funding round 5 years after it was founded.
Echelon Biosciences is headquartered in Salt Lake City, United States. It is registered at Salt Lake City, Utah, United States.
Echelon Biosciences is a biotech company manufacturing reagents and assays with a strong focus on research on lipid biology. The company was formed in 1997 as a spin-off from the Center for Cell Signaling at the University of Utah and changed hands once in 2005 (Aeterna Zentaris) before being acquired by Frontier Scientific Inc. in 2007. The companys focus is on the development of novel assays and reagents for lipid research and drug discovery (with a focus on cancer, liver disease, allergies, Type II diabetes, and anti-infectives). The companys products include chemical reagents (such as phosphoinositide derivatives, inositol phosphates, lipids, isoprenoids, Heme pathway intermediates, and thiol-reactive probes), biological reagents (such as lipid modifying enzymes, kinases and phosphatases, histone modifying enzymes, enzyme inhibitors and substrates, antibodies and antigens, LPA3 selective ligands, lipid coated beads, lipid strips and arrays, lipid coated plates and microarrays, reagents for lipid delivery, cell viability studies, DNARNA purification) and assays (such as kinase assays, phosphatase assays, hydrolase assays, lipid detection assays, biomarker assays, etc). The company also provides protein detection and assay development services to clients.
Echelon Biosciences's top competitors include GlyTech, Iceni Glycoscience and GlycoSpot.
Echelon Biosciences offers Lipids, Bioassays & Kits, Antibodies & Proteins, Peptides, and Biochemical Reagents.
Echelon Biosciences has 5 investors. Key investors include NIH, HHS, National Science Foundation, VION Biosciences, and Frontier Chemical.